Purchase Order HT001424P0125
- Not listed
- This is a firm fixed price delivery order awarded by the Office of Administrative Services Procurement Management Branch, a civilian federal agency, to Illumina, Inc. for the provision of ILLUMINA SUPPLIES. The contract has a ceiling value of $302,813.03 and a period of performance through March 19, 2025. No set-aside was used. Illumina is an established provider of sequencing and genomic analysis instruments and reagents, having supported research and diagnostic needs across various federal...
- This is a firm fixed-price purchase order contract awarded by the U.S. Army Medical Command to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions. The contract is for a SEQUENCING SYSTEM with a ceiling value of $1,084,390.80 and a period of performance that runs through November 22, 2020. The contract does not have a set-aside designation. Illumina has provided sequencing systems, reagents, and services to support genomic research and analysis for various federal...
- This firm fixed-price delivery order contract was awarded by the Plains Area agency of the U.S. federal government to Illumina, Inc. for the provision of two Illumina sequencing systems (SN: VH00839 & VH00841) and associated services. The total ceiling value of the contract is $90,150.80 and the ultimate completion date is January 3, 2025. Illumina is a manufacturer of sequencing and genomic analysis instruments and reagents, and has a history of prior federal contract and sub-contract...
- This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency, to Illumina, Inc. for the provision of biological kits. The contract has a ceiling value of $225,143.94 and a completion date of July 27, 2024. Illumina, a for-profit manufacturer of genomic sequencing and analysis products, has a history of providing sequencing systems, reagents, and related services to various federal agencies for research and diagnostic applications. This...
- This is a firm fixed-price purchase order worth $499,633.76 awarded by the Defense Health Agency to Illumina, Inc. for the procurement of a NEXTSEQ 550 SEQUENCING SYSTEM. The contract has no set-aside designation. Illumina has been a long-standing provider of sequencing instruments, reagents, and bioinformatics solutions to various federal agencies, including the NIH, CDC, USDA, and VA, to support genomic research and diagnostics. While this appears to be a standalone purchase order, Illumina...
- This is a firm fixed price purchase order awarded by the Defense Health Agency to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $197,939.00 contract is for a testing and maintenance agreement for two pathology instruments. The contract has no set-aside designation. Through prior prime contract awards, Illumina has provided sequencing systems and related goods and services to support genomic research and analysis across various federal agencies,...
- This is a firm fixed price delivery order awarded by the National Cancer Institute (NCI), a civilian agency under the U.S. Department of Health and Human Services, to Illumina, Inc. for the provision of biological kits. The order has a ceiling value of $45,077.60 and a period of performance through April 30, 2025. Illumina, a manufacturer of sequencing and genomic analysis products, has previously received prime federal contracts and subcontracts from agencies like NIH, CDC, USDA, and VA to...
- This is a firm fixed-price federal purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to the for-profit manufacturer Illumina, Inc. The contract has a ceiling value of $88,110.00 and an ultimate completion date of April 28, 2020. The contract does not have any set-aside designation. Under this contract, Illumina will provide a range of genomic sequencing systems, reagents, consumables, and related services to the NIH, which conducts biomedical and public...
- This is a firm fixed price delivery order awarded by the National Institutes of Health (NIH) Clinical Center to Illumina, Inc. for the provision of Illumina reagent kits. The order, valued at $52,407.45, has a period of performance through September 30, 2024. There was no set-aside designation for this award. Based on Illumina's prior federal contract work, the company has provided a range of genomic sequencing instruments, reagents, and related services to support research and diagnostics...
- This is a firm fixed price delivery order awarded by the Office of Administrative Services Procurement Management Branch, a civilian agency, to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $98,056.80 order is for Illumina kits with no set-aside designation. Illumina has a history of providing sequencing systems and consumables to support genomic research and diagnostics across various federal agencies including NIH, CDC, USDA, and VA. This...
This is a firm fixed price purchase order contract awarded by the Defense Health Agency to Illumina, Inc. for the TRUSIGHT ONCOLOGY 500 BUNDLE. The contract has a ceiling value of $197,786.89 and a period of performance through September 30, 2024. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, has provided similar products and services to various federal agencies in the past, including the National Institutes of Health, Centers for Disease Control, Department of Agriculture, and Department of Veterans Affairs. The contract does not have a set-aside designation. This award appears to be part of a larger Indefinite Delivery Contract that Illumina holds with the Department of the Navy Bureau of Medicine and Surgery, valued at up to $3.3 million, to support nucleic acid sequencing needs for the Naval Medical Research Center's Biological Defense Research Directorate.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 6/13/24 | |
| Not listed | Not listed | $197.8k | 5/23/24 |